Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Detection of hepatitis G virus (HGV) RNA and antibodies to the HGV envelope protein E2 in a cohort of hemodialysis patients.

Literature DB >> 11060111

Detection of hepatitis G virus (HGV) RNA and antibodies to the HGV envelope protein E2 in a cohort of hemodialysis patients.

T Pérez-Gracia¹, F Galán, J A Girón-González, A Lozano, B Benavides, E Fernández, M Rodríguez-Iglesias.

Abstract

An analysis of the evolution of hepatitis G virus (HGV) infection markers was performed for a cohort of 58 hemodialyzed patients. During follow-up (4.88 +/- 0.42 years), a group of these patients cleared their antibodies against the envelope protein E2 with (4 of 29 cases; 13.8%) or without (9 of 29 cases; 31%) the reappearance of viremia. This finding implies a temporally limited protection in patients previously infected with HGV.

Entities: Disease Species

Mesh：

Substances：

Year: 2000 PMID： 11060111 PMCID： PMC87584

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

17 in total

1. Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications.

Authors: X Forns; P Fernández-Llama; J Costa; F X López-Labrador; S Ampurdanés; E Olmedo; J C Saiz; M Guilera; J López-Pedret; J M Sánchez-Tapias; A Darnell; M T Jimenez de Anta; A Ordinas; J Rodés
Journal: Nephrol Dial Transplant Date: 1997-05 Impact factor: 5.992

2. Prevalence of present and past hepatitis G virus infection in a French haemodialysis centre.

Authors: J F Desassis; S Laperche; A Girault; A Kolko; F Bouchardeau; B Zins; J L Poignet; A M Couroucé
Journal: Nephrol Dial Transplant Date: 1999-11 Impact factor: 5.992

3. Hepatitis GB virus C in patients on hemodialysis.

Authors: X de Lamballerie; R N Charrel; B Dussol
Journal: N Engl J Med Date: 1996-06-06 Impact factor: 91.245

4. Hepatitis G virus infection in hemodialysis patients.

Authors: M Sampietro; S Badalamenti; G Graziani; G Como; G Buccianti; N Corbetta; A Ticozzi; A Archenti; G Lunghi; D Penso; A Pizzuti; G Fiorelli; C Ponticelli
Journal: Kidney Int Date: 1997-01 Impact factor: 10.612

5. GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells in hemodialysis patients.

Authors: M Cabrerizo; J Bartolomé; P De Sequera; C Caramelo; M L Manzano; V Carreño
Journal: Kidney Int Date: 1999-09 Impact factor: 10.612

6. Prevalence and disease association of hepatitis G virus infection in Japan.

Authors: Y Nakatsuji; J W Shih; E Tanaka; K Kiyosawa; J Wages; J P Kim; H J Alter
Journal: J Viral Hepat Date: 1996-11 Impact factor: 3.728

7. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology.

Authors: M Yoshiba; H Okamoto; S Mishiro
Journal: Lancet Date: 1995-10-28 Impact factor: 79.321

8. Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia.

Authors: F Tsuda; S Hadiwandowo; N Sawada; M Fukuda; T Tanaka; H Okamoto; Y Miyakawa; M Mayumi
Journal: J Med Virol Date: 1996-07 Impact factor: 2.327

9. Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine.

Authors: P Jungers; P Devillier; H Salomon; J E Cerisier; A M Courouce
Journal: Lancet Date: 1994-09-24 Impact factor: 79.321